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Case Report 
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Inflammatory myofibroblastic tumour (IMT) is a rare neoplasm. Generally, these lesions have a benign
behaviour, but the possibility of malignant transformation exists. We report the rare case of a 43-year-old
woman with metachronous IMTs in the spleen and the liver. The patient was treated with laparoscopic
splenectomy and partial hepatectomy. The patient recovered uneventfully. This case emphasizes the diffi-
culties in diagnosis and the possibility of a metachronous occurrence. [Asian J Surg 2008;31(1):25–8]
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Introduction
Inflammatory myofibroblastic tumour (IMT) is a rare
condition. There are a variety of synonyms for this tumour
including plasma cell granuloma, postinflammatory
tumour, xanthomatous pseudotumour, inflammatory
pseudotumour and inflammatory fibrosarcoma.1 By defi-
nition, the tumour is composed of dominant spindle cell
proliferation with a variable inflammatory component.
These spindle cells are now known to be myofibroblasts
and this is the reason for the current designation for this
disease. IMT may affect individuals of any age, but it has
a predilection for children and young adults. It is most
commonly found in the lung, but is also reported in the
central nervous system, salivary glands, larynx, breasts,
pancreas, spleen, lymph nodes, skin and liver. As the syn-
onyms suggest, there is some confusion as to whether
IMT is truly neoplastic or whether it represents a reactive
proliferation of myofibroblastic cells. It is now generally
accepted that IMT is a true neoplasm. These lesions have
a benign behaviour, but the possibility of malignant trans-
formation exists.2–4 We report the case of a 43-year-old
woman with metachronous IMTs in the spleen and the liver.
Case report
A 43-year-old woman had a past history of laparoscopic
splenectomy for splenic abscess in our hospital 5 years
ago. Otherwise, she had a good past medical health. She
was referred again to our hospital for an incidental find-
ing of two liver tumours during routine health evaluation
by abdominal ultrasonography. Physical examination did
not show any stigmata of chronic liver disease or
hepatomegaly. Bilirubin, liver transaminases and alkaline
phosphatase levels were all normal. Hepatitis serology of
HBsAg and anti-HCV, α-fetoprotein, and carcinoembry-
onic antigen were negative.
Computed tomography scan of the abdomen showed
two contrast-enhanced masses measuring 6.3 × 5.5 × 5.3 cm
at liver segments 6 and 7 and 2.8 × 1.8 × 1.7 cm at segment
8 (Figure 1). Hepatocellular carcinoma with a satellite
nodule was suspected. However, magnetic resonance
imaging showed radiologic features of benign liver lesions
(Figure 2). Ultrasound-guided liver tumour biopsy showed
features of IMT (Figure 3). For this, the histology of the
previously resected splenic lesion was reviewed again by
experienced pathologists. The diagnosis was revised to
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Figure 1. Contrast-enhanced computed tomography scan of the liver showed a lobulated mass at segments 6 and 7 and a satellite
nodule at segment 8.
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Figure 2. Magnetic resonance imaging of the two liver masses showed low to iso-intensity on T1-weighted images, and heterogeneous
high intensity on T2-weighted images. After administration of Gd-DTPA, the masses showed delayed enhancement.
IMT of the spleen from the previous diagnosis of splenic
abscess (Figure 4). The patient underwent resection of
hepatic segments 6, 7 and 8 in June 2006 (Figure 5).
Microscopically, the tumours were characterized by a
proliferation of spindle cells with intermingled inflam-
matory cells (lymphocytes, plasma cells, eosinophils).
Numerous special stains were performed. The spindle
cells were immunopositive for vimentin, smooth muscle
actin and CD68. Negative staining was noted for EMA,
ALK, desmin, CK, CD12, CD117, CD21, CD34, S100 and
FVIII. There was no evidence of dysplasia or malignancy.
Cellular mitosis was seen. The pathological diagnosis of
IMT was made. The patient recovered well from surgery.
She was well and without evidence of disease 6 months
after the partial hepatectomy.
Discussion
Historically, the medical literature on IMT has been con-
fined to small case series involving a single organ, with few
reports encompassing multiple anatomic sites. Although
the lung is the best known and the most common site,
IMT occurs in diverse extrapulmonary locations.5 We
reported a rare case of metachronous IMT of the spleen
and the liver.
On gross examination, IMT tends to be circumscribed
or multinodular, firm, white or tan, with a whorled fleshy,
fibrotic or myxoid cut surface. The surface may show a
variegated appearance with areas of necrosis and haemo-
rrhage in a minority of cases. Microscopically, three basic
histological patterns are recognized: (1) myxoid, vascular,
and inflammatory areas resembling nodular fasciitis; (2)
compact spindle cells with intermingled inflammatory
cells (lymphocytes, plasma cells, eosinophils) resembling
fibrous histiocytoma; and (3) dense plate-like collagen
resembling a desmoid or scar.2 Generally, there is little pleo-
morphism or mitotic activity. Immunohistochemistry is a
valuable adjunct to light microscopic diagnosis. Vimentin
is almost invariably positive in the spindle cells. Smooth
muscle actin and muscle specific actin are present in the
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Figure 3. Photomicrograph of inflammatory myofibroblastic
tumour of the liver shows proliferation of spindle cells with intermin-
gled inflammatory cells (lymphocytes, plasma cells, eosinophils).
There is no dysplasia or malignancy. Mitotic activity can be seen.
(Haematoxylin & eosin, 100×.)
Figure 4. Photomicrograph of inflammatory myofibroblastic
tumour of the spleen shows proliferation of spindle cells with
intermingled inflammatory cells (lymphocytes, plasma cells, eosin-
ophils). Multiple foci of abscesses can be seen. (Haematoxylin &
eosin, 100×.)
Figure 5. Photograph of the resected liver segments shows 
two well-circumscribed, unencapsulated, round and lobulated
masses, measuring 8 × 5 cm at segments 6 and 7 and 2 × 2 cm at
segment 8.
majority of cases. Desmin, CD68, pankeratin and p53 are
positive in some cases. S100, CD21 and myoglobin are
uniformly negative.
The aetiology and pathogenesis of IMT remain
unknown, although the tumours were initially thought
to represent a reactive inflammatory process. Aetiological
causes, including infections, vascular causes and auto-
immune disorders, have been hypothesized in their 
pathogenesis.6–8 Some authors have hypothesized that
microorganisms from certain conditions, such as appen-
dicitis, seed the hepatic parenchyma through the portal
vein, creating an inflammatory reaction with obliterating
phlebitis and granulomata formation.7 Some cases were
reported to be Epstein-Barr virus (EBV)-positive inflam-
matory follicular dendritic cell tumours.8 However, this
theory is doubtful because no evidence of infectious
organisms could be demonstrated in most of the other
reported series. In our patient, no acid-fast organisms,
fungi, parasites, or bacteria could be identified and EBV
was not detected on in situ hybridization. Vascular cause 
is another hypothesis and it is believed by some authors
that these lesions may be due to intraparenchymatous
haemorrhage secondary to trauma or coagulopathy.9 The
high content of plasma cells in this lesion suggests the
hypothesis of immunological origin of this disease.10
The diagnosis of IMT is often difficult, despite the use
of modern imaging and laboratory techniques, and gen-
erally these masses are often confused with other lesions,
such as primary or secondary neoplasm, because the clin-
ical presentations and morphological appearances are
often nonspecific.11 For the diagnosis of IMT of the
spleen, fine needle aspiration biopsy may cause haemo-
rrhage and the results may be misleading due to the pres-
ence of inflammatory and mesenchymal cells. Therefore,
most authors advocate surgery for the diagnosis and
treatment of IMT of the spleen. Nowadays, laparoscopic
splenectomy can be used for definitive diagnosis and
symptomatic relief with minimal morbidity and mortality.
In contrast, the treatment options for IMT of the liver are
varied. Surgery, high-dose steroids, irradiation, and chemo-
therapy have been reported. Spontaneous regression has
also been reported in some cases of IMT.12 Although
some authors have suggested only simple observation or
conservative therapy with steroids or nonsteroidal anti-
inflammatory drugs if an accurate diagnosis of IMT is
made, surgical resection is the preferred treatment for
IMT of the liver, especially in patients for whom a definite
histological diagnosis cannot be made preoperatively 
or by intraoperative frozen sections. The natural course
of IMT without resection is unclear. A small proportion of
patients with local recurrence or metastases after partial
hepatectomy have been recorded.3,4 In fact, most patients
reported in the medical literature recovered uneventfully
after partial hepatectomy. Since the morbidity and mor-
tality of partial hepatectomy in noncirrhotic livers is low,
surgical resection with clear margins should be considered
as the treatment of choice for IMT.
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